Quintiles: clinical trial complexity demands innovative approaches
Quintiles has announced a new model designed to accelerate site start-up and patient recruitment in oncology clinical trials to 21 days.
Quintiles has announced a new model designed to accelerate site start-up and patient recruitment in oncology clinical trials to 21 days.
Industry backing for a G7 plan to preserve antibiotics is at odds with current marketing practices says an NGO calling for a clamp down on campaigns that promote overuse.
Roche’s subcutaneous formulation of MabThera is about reducing the treatment burden for patients and not protecting it from impending biosimilar competition, the firm says.
Rising drug prices and the subsequent increasing number of drugs ineligible for reimbursement will challenge drug developers to provide clinical superiority evidence.
The US FDA has told Megafine Pharma it must determine the extent of data falsification at the plant in Nashik, Maharashtra that was banned from shipping APIs to the US last year.
Q&
Envigo has appointed Scott Schulz, MBA, to the post of Director, North American Operations.